A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune ...

† Laboratory of Solid State Microstructures and Innovation Center of Advanced Microstructures, Nanjing University, Nanjing 210093, China § Institute for Advanced Materials and Laboratory of Quantum ...

Background Wolf–Hirschhorn syndrome (WHS) is a contiguous gene deletion syndrome involving variable size deletions of the 4p16.3 region. Seizures are frequently, but not always, associated with WHS.